Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Therapy With and Without Cetuximab in Patients With Locally Advanced Esophageal Carcinoma - An Open-Label Phase III Trial

NCT01107639 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT01107639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01107639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Therapy With and Without Cetuximab in Patients With Locally Advanced Esophageal Carcinoma - An Open-Label Phase III Trial
Lead sponsor
Swiss Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
May 27, 2010
Completion date
December 9, 2018
Enrollment
297 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the gastroesophageal junction, esophageal cancer